Vir Biotechnology (VIR) EBT Margin Growth (1y) (2019 - 2026)
Vir Biotechnology (VIR) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - | -42.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.89 Mn |
| Dec 31, 2025 | 77,872.00 |
| Sep 30, 2025 | -5.89 Mn |
| Jun 30, 2025 | -457,660.00 |
| Mar 31, 2025 | -386,336.00 |
| Dec 31, 2024 | -12,658.00 |
| Sep 30, 2024 | -265,829.00 |
| Jun 30, 2024 | 65,545.00 |
| Mar 31, 2024 | 10,171.00 |
| Dec 31, 2023 | -41,245.00 |
| Sep 30, 2023 | -637,211.00 |
| Jun 30, 2023 | -462,946.00 |
| Mar 31, 2023 | -30,224.00 |
| Dec 31, 2022 | -37,406.00 |
| Sep 30, 2022 | -4,877.00 |
| Jun 30, 2022 | -61,202.00 |
| Mar 31, 2022 | 861,301.00 |
| Dec 31, 2021 | 680,102.00 |
| Sep 30, 2021 | 449,419.00 |
| Jun 30, 2021 | 10,863.00 |